Granules Pharmaceuticals

Building on Granules India’s global manufacturing strength, Granules Pharmaceuticals Inc. (GPI) is a 100% US-based subsidiary committed to delivering high-quality, affordable pharmaceutical solutions. Located in Chantilly, Virginia, our US FDA and DEA-approved facility spans over 100,000 square feet and is equipped with established R&D and manufacturing capabilities.

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore Pharmaceuticals profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Granules Pharmaceuticals.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Building on Granules India’s global manufacturing strength, Granules Pharmaceuticals Inc. (GPI) is a 100% US-based subsidiary committed to delivering high-quality, affordable pharmaceutical solutions. Located in Chantilly, Virginia, our US FDA and DEA-approved facility spans over 100,000 square feet and is equipped with established R&D and manufacturing capabilities.

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.